Eterna Therapeutics
ERNA
$1.90
Share price
3.83%
Change (1 day)
-9.09%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Total assets
Total assets on the balance sheet as of March 2024 : $49.65 M
According to Eterna Therapeutics's latest financial reports the company's total assets are $49.65 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Eterna Therapeutics - Total assets on balance sheet (from 2020 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $22.27 M | -29.33% |
| 2021-12-31 | $31.52 M | 144.27% |
| 2020-12-31 | $12.9 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $139.81 B | 281,463.53% | 🇫🇷 France |
 Baxter BAX | $27.78 B | 55,859.88% | 🇺🇸 USA |
 Omeros Corporation OMER | $0.43 B | 781.03% | 🇺🇸 USA |
 Geron GERN | $0.48 B | 870.81% | 🇺🇸 USA |
 Genetic Technologies GENE | $5.77 M | -88.37% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $42.77 B | 86,036.90% | 🇮🇱 Israel |
 Bio-Techne TECH | $2.72 B | 5,379.93% | 🇺🇸 USA |